IP Library Granted Patent US 7,687,641
Granted Patent B2
US 7,687,641 · App. 11/785,997 · Granted Mar 30, 2010

Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,687,641
App. No.
11/785,997
Granted
Mar 30, 2010
Kind
B2
Abstract

Methods of using di, tri, and tetracyclic acylhydrazide derivatives and analogs, as well as pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated therewith, particularly those viral infections and associated diseases cased by the orthopoxvirus.

Claims (20)

1. A process for producing ST-246

of the formula comprising the steps of:

a) heating a mixture of anti-tricyclo[3.2.2.0]non-6-ene-endo-8, endo-9-dicarboxylic acid anhydride, 4-(trifluoromethyl)benzhydrazide, and ethanol at reflux to form a solution;

b) cooling the solution;

c) concentrating the solution to form a residue; and

d) recrystallizing the residue from ethyl acetate and hexanes to obtain ST-246.

2. The process of claim 1 , wherein the mixture of step (a) is heated for about 18 hours.

3. The process of claim 1 , wherein the mixture of step (a) is heated under an inert atmosphere.

4. The process of claim 3 , wherein the inert atmosphere consists essentially of nitrogen.

5. The process of claim 3 , wherein the inert atmosphere consists essentially of argon.

6. The process of claim 1 , wherein the cooling of step (b) is to about room temperature.

7. The process of claim 1 , wherein the solution is concentrated under reduced pressure.

8. The process of claim 7 , wherein the reduced pressure of step (c) is a vacuum.

9. The process of claim 1 , wherein the solution is concentrated by rotary evaporation.

10. A process for producing ST-246

of the formula comprising the steps of:

heating a mixture of anti-tricyclo[3.2.2.0]non-6-ene-endo-8, endo-9-dicarboxylic acid anhydride, 4-(trifluoromethyl)benzhydrazide, and ethanol at reflux for 18 hours under a nitrogen atmosphere to form a solution;

cooling the solution to room temperature;

concentrating the solution in vacuo to form a residue; and

recrystallizing the third residue from ethyl acetate and hexanes to obtain ST-246.

Assignments (4)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 40349/0219 Recorded Mar 13, 2020
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 052163/0014 →
SECURITY INTEREST Recorded Nov 16, 2016
From: SIGA TECHNOLOGIES, INC.
To: CORTLAND CAPITAL MARKET SERVICES, LLC
Reel/Frame 040349/0219 →
CONFIRMATORY LICENSE Recorded Dec 12, 2011
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027365/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2007
From: JORDAN, ROBERT F.; BAILEY, THOMAS R.; RIPPIN, SUSAN R.; DAI, DONGCHENG
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 019572/0560 →